Expression of lymphoid enhancer factor/T-cell factor proteins in colon cancer

Marian L Waterman1

  • 1Department of Microbiology and Molecular Genetics, College of Medicine, University of California, Irvine, Irvine, California 92697, USA. mlwaterm@uci.edu

Insights

Colon cancer progression involves the Wnt signaling pathway. Selective expression of activating lymphoid enhancer factor/T-cell factor (LEF/TCF) forms may drive tumor growth, while suppressing truncated forms are disfavored.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Wnt signaling pathway is crucial in early colon tumor development.
  • Mutations in Wnt pathway components can lead to ligand-independent activation, driving continuous target gene expression changes.
  • Lymphoid enhancer factor/T-cell factor (LEF/TCF) transcription factors are key mediators connecting Wnt signals to target genes.

Purpose of the Study:

  • To investigate the role of LEF/TCF family members in colon cancer progression.
  • To understand how different forms of LEF/TCFs (full-length vs. truncated) contribute to Wnt signaling in malignancy.

Main Methods:

  • Molecular genetic analysis of colon cancer tissues.
  • Analysis of gene expression patterns for TCF7 and LEF1.

Main Results:

  • The study suggests a shift in LEF/TCF expression during colon cancer progression.
  • There appears to be selective expression of activating, full-length LEF/TCF forms.
  • Expression of dominant-negative, truncated LEF/TCF forms, which may suppress growth, seems to be reduced.

Conclusions:

  • Wnt signaling plays a significant role in the malignancy of colon cancers.
  • The observed expression bias towards activating LEF/TCF forms may strengthen the Wnt signal.
  • A reduced presence of growth-suppressing truncated LEF/TCF forms could contribute to tumor progression.